TCL Archive ACCC Seeking Line Item, $21 Million for CCPs; Results Of Evaluation Released June 5, 1987
TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004